Neuronal Nicotinic Acetylcholine Receptors - Targets for the Development of Drugs to Treat Cognitive Impairment Associated with Schizophrenia and Alzheimer's Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|10|2|144-152

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.10, Iss.2, 2010-02, pp. : 144-152

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Serotonin Receptors as Targets for Drugs Useful to Treat Psychosis and Cognitive Impairment in Schizophrenia

By  

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 8, 2012-06 ,pp. : 1572-1586

Bentham Science Publishers

Access to resources Recommend Favorite

Neuronal nicotinic acetylcholine receptors as drug targets

By Suto Mark J   Zacharias Niki  

Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 2, 2004-04 ,pp. : 61-64

Informa Healthcare

Access to resources Recommend Favorite

Alpha7 Neuronal Nicotinic Receptors as Targets for Novel Therapies to Treat Multiple Domains of Schizophrenia

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 3, 2011-03 ,pp. : 437-448

Bentham Science Publishers

Access to resources Recommend Favorite

Neuronal Nicotinic Acetylcholine Receptors as Pharmacotherapeutic Targets for the Treatment of Alcohol Use Disorders

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 1, 2010-03 ,pp. : 60-76

Bentham Science Publishers

Access to resources Recommend Favorite

Neuronal Acetylcholine Nicotinic Receptors as New Targets for Lung Cancer Treatment

By  

Current Pharmaceutical Design, Vol. 22, Iss. 14, 2016-04 ,pp. : 2160-2169

Bentham Science Publishers

Access to resources Recommend Favorite